As investors globally navigate through the complexities of trade tensions and technological disruptions, dividend-paying stocks like BioGaia offer a semblance of stability and potential for steady ...

We're going to check out a few of the best picks from our screener tool. Overview: BioGaia AB (publ) is a healthcare company that offers probiotic products globally, with a market capitalization ...

BioGaia reported robust financial results for the fourth quarter of 2024, driven by significant sales growth and strategic ...

STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: BioGaia (STO:BIOG-B) has previously owned 50 per cent of TwoPac AB and the remaining shares have been held by TwoPac’s management.

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops ...

EQT Public Value to invest in BioGaia through participation in a directed issue As an active and long-term owner, EQT Public Value intends to work closely with existing shareholders, the board of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In light of these benefits and no signs of toxicity, early initiation of BioGaia ProTectis is a standard of practice in our neonatal intensive care unit which has continued to prevent NEC in our ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

2015-10-26 BioGaia signs exclusive agreement in Sri Lanka 2015-10-23 BioGaia AB Interim Management statement 1 January – 30 September 2015 BioGaia has published this information in accordance ...

BioGaia's total investment in IBT thus amounts to approximately SEK 82 million and its holding to 94.5 per cent. Efforts to evaluate the possibility for a separate listing of IBT are continuing.